A disease so old and basic that we barely think about it, even though it affects almost 700,000 Americans a year, is overcoming the last antibiotics now available to treat it.
That last request hints at why the emergence of gonorrhea has been so hard to control. The bacterium is very good at amassing mutations that protect it against antibiotics. It churned through sulfa drugs, the first antibacterials, in the 1940s; penicillin and tetracycline, some of the earliest antibiotics, by the 1980s; and fluoroquinolones such as Cipro by the mid-2000s.
“We know that clinicians often aren’t super comfortable talking about sexual health, and patients aren’t either,” says Elizabeth Finley, director of communications at the National Coalition of STD Directors, the professional association for STD chiefs such as Roosevelt. “So recommendations to be tested can get skipped over, or requests aren’t heard.”
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Drug for delaying diabetes wins landmark approval - Nature BiotechnologyThe November approval of Tzield (teplizumab) marks a turning point in the management of type 1 diabetes.
Baca lebih lajut »
Experts urge better opioid rescue drug access to save livesA drug that reverses opioid overdoses has become far more accessible in the U.S. But naloxone is still frustratingly unavailable in many of the moments when it’s needed. A Georgia mom and nurse is one of the people driven to get it to people who use drugs.
Baca lebih lajut »
Drugmakers prevail in dispute over U.S. discount drug programDrug manufacturers can limit healthcare providers' use of outside pharmacies for dispensing drugs under a federal drug discount program, a federal appeals court ruled Monday.
Baca lebih lajut »
Promising Antimalarial Drug Proves Ineffective at Saving Children’s LivesAccording to a study conducted by the Swiss Tropical and Public Health Institute (Swiss TPH) and partners, results show that the promising antimalarial drug, rectal artesunate (RAS), is ineffective at saving the lives of young children who are suffering from severe malaria. The viewpoint about the s
Baca lebih lajut »